Skip to main content
Journal cover image

Pharmacogenetic guidance for antiplatelet treatment.

Publication ,  Journal Article
Jeong, Y-H; Bliden, KP; Park, Y; Tantry, US; Gurbel, PA
Published in: Lancet
August 25, 2012

Duke Scholars

Published In

Lancet

DOI

EISSN

1474-547X

Publication Date

August 25, 2012

Volume

380

Issue

9843

Start / End Page

725

Location

England

Related Subject Headings

  • Purinergic P2Y Receptor Antagonists
  • Precision Medicine
  • Point-of-Care Systems
  • Platelet Aggregation Inhibitors
  • Male
  • Humans
  • Genetic Testing
  • Genetic Carrier Screening
  • General & Internal Medicine
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jeong, Y.-H., Bliden, K. P., Park, Y., Tantry, U. S., & Gurbel, P. A. (2012). Pharmacogenetic guidance for antiplatelet treatment. Lancet, 380(9843), 725. https://doi.org/10.1016/S0140-6736(12)61398-1
Jeong, Young-Hoon, Kevin P. Bliden, Yongwhi Park, Udaya S. Tantry, and Paul A. Gurbel. “Pharmacogenetic guidance for antiplatelet treatment.Lancet 380, no. 9843 (August 25, 2012): 725. https://doi.org/10.1016/S0140-6736(12)61398-1.
Jeong Y-H, Bliden KP, Park Y, Tantry US, Gurbel PA. Pharmacogenetic guidance for antiplatelet treatment. Lancet. 2012 Aug 25;380(9843):725.
Jeong, Young-Hoon, et al. “Pharmacogenetic guidance for antiplatelet treatment.Lancet, vol. 380, no. 9843, Aug. 2012, p. 725. Pubmed, doi:10.1016/S0140-6736(12)61398-1.
Jeong Y-H, Bliden KP, Park Y, Tantry US, Gurbel PA. Pharmacogenetic guidance for antiplatelet treatment. Lancet. 2012 Aug 25;380(9843):725.
Journal cover image

Published In

Lancet

DOI

EISSN

1474-547X

Publication Date

August 25, 2012

Volume

380

Issue

9843

Start / End Page

725

Location

England

Related Subject Headings

  • Purinergic P2Y Receptor Antagonists
  • Precision Medicine
  • Point-of-Care Systems
  • Platelet Aggregation Inhibitors
  • Male
  • Humans
  • Genetic Testing
  • Genetic Carrier Screening
  • General & Internal Medicine
  • Female